A trial of scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 27, Issue 4, 2013, Pages 359-364

  Coyne, Patrick J ^a   Wan, Wen ^b   Dodson, Patricia ^a   Swainey, Craig ^a   Smith, Thomas J ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Analgesics; Chemotherapy induced peripheral neuropathy; Chronic neuropathic pain; Electroanalgesia; Refractory pain; Scrambler therapy

Indexed keywords

BORTEZOMIB; CARBOPLATIN; CISPLATIN; DOCETAXEL; OXALIPLATIN; PACLITAXEL; VINCRISTINE;

ACUTE DISEASE; ADULT; ANALGESIA; ARTICLE; BRIEF PAIN INVENTORY; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PATIENT; CHRONIC PAIN; CLINICAL ARTICLE; EUROPEAN ORGANIZATION FOR TREATMENT AND CANCER SCALE; FEMALE; HUMAN; MALE; MOOD; MOTOR PERFORMANCE; NERVE STIMULATION; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; RATING SCALE; SCRAMBLER THERAPY; SENSORY EVALUATION; TREATMENT OUTCOME; WALKING;

ANTINEOPLASTIC AGENTS; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN MANAGEMENT; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; QUALITY OF LIFE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84890100770     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360288.2013.847519     Document Type: Article

References (18)

1. Botez SA, Herrmann DN. Sensory neuropathies, from symptoms to treatment. Curr Opin Neurol. 2010;23(5):502-508.
2. Marineo G. Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP. 2003;4(1):1-10. (Pubitemid 38963793)
3. Sabato AF, Marineo G, Gatti A. Calmare therapy. 2005 Minerva Anestesiol. 71(7-8):479-482.
4. Smith TJ, Coyne PJ, Parker G, Dodson P. Pilot trial of a Patient-specific Cutaneous Electro-stimulation Device (MC5-A Calmare R-) for Chemotherapy Induced Peripheral Neuropathy. J Pain SymptomManage. 2010;40(6):883-891.
5. Pachman DR, Linquist BM, Barton DL, Fee-Schroeder KC, Smith TJ, Lachance Dh, et al. Pilot study of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy. J Clin Oncol. 2012;30: (suppl., abstr 9075)
6. Ricci M, Pirotti S, Scarpi E, Burgio M, Maltoni M, Sansoni E, Amadori D. Managing chronic pain: results from an openlabel study using MC5-A Calmare R-device. Support Care Cancer. 2012;20(2):405-412. Epub 2011 Mar 11.
7. Ko YK, Lee HY, Lee WY. Clinical experiences on the effect of scrambler therapy for patients with postherpetic neuralgia. Korean J Pain. 2013;26(1):98-101. doi: 10.3344/kjp.2013.26. 1.98. Epub 2013 Jan 4. PMID:23342218
8. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13(11):1153-1169. (Pubitemid 44581463)
9. Ko YK, Lee HY, Lee WY. Clinical experiences on the effect of scrambler therapy for patients with postherpetic neuralgia. Korean J Pain. 2013;26(1):98-101. doi: 10.3344/kjp.2013.26.1.98. Epub 2013 Jan 4.
10. Park HS, Sin WK, Kim HY, Moon JY, Park SY, Kim YC, Lee SC. Scrambler therapy for patients with cancer pain: case series. Korean J Pain. 2013;26(1):65-71. doi: 10.3344/kjp.2013.26.1.65. Epub 2013 Jan 4.
11. Ghatak RK, Nandi SN, Bhakta A, Mandal GC, Bandyopadhyay M, Kumar S. Prospective study of application of biological communication (cybernatics) in management of chronic low back pain-a preliminary report. Nepal Med Coll J. 2011;13(4):257-260.
12. Sparadeo F, Kaufman C, D'Amato S. Scrambler therapy: an innovative and effective treatment for chronic neuropathic pain. J Life Care Planning. 2012;11(3):3-15.
13. Marineo G, Iorno V, Gandini C, Moschini V, Smith TJ. Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial. J Pain Symptom Manage. 2012;43(1):87-95. doi: 10.1016/j.jpainsymman.2011.03.015. Epub 2011 Jul 16.
14. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13(11):1153-1169. (Pubitemid 44581463)
15. Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, et al. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain. 2010;149(2):177-193.
16. Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, et al. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain. 2009;146(3):238-244.
17. Farrar JT, Young JP Jr., LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-158. (Pubitemid 33016608)
18. Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013;309(13):1359-1367. doi: 10.1001/jama.2013.2813.